Brief: Neurovive Receives Sek 28.2 Million In A Directed New Share Issue
NeuroVive Pharmaceutical AB NVP.ST :
* NEUROVIVE RECEIVES SEK 28.2 MILLION IN A DIRECTED NEW
SHARE
ISSUE
* NEUROVIVE PHARMACEUTICAL AB - THESE PROCEEDS WILL BE USED
PRIMARILY TO ACCELERATE CLINICAL DEVELOPMENT ACTIVITIES
Source text for Eikon: ID:nWkr4SyTHm
Further company coverage: NVP.ST